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Introduction: Leptospirosis presents with disease of variable severity; multi-organ failure can occur. In this situation,
plasma exchange has been used with positive results, although the mechanism of action has not been fully explained.
Case presentation: A 67-year-old Caucasian man developed severe leptospirosis with marked icterus, acute kidney
injury and cardiorespiratory failure, after exposure to livestock. On the basis of previous reported cases, he was treated
with plasma exchange. This led to a rapid improvement in his bilirubin level, cardiac and respiratory function, followed
by renal function.
Conclusion: We discuss the pathophysiology of the disease, and suggest that plasma exchange has a role in the
treatment of severe sepsis caused by leptospirosis as well as immune complex-mediated organ injury.Introduction
Leptospirosis is caused by the Leptospira species of Spi-
rochaetes and is presumed to be the world’s most com-
mon zoonosis. Infection usually follows contact with the
urine of infected animals through broken or water-
soaked skin or the conjunctivae. The largest reservoir of
infection is rats, although leptospires have been isolated
from cattle populations, and contact with livestock is an
established risk factor [1]. In the United Kingdom there
are around 60 serologically proven cases per year [2], al-
though the incidence is far higher in tropical countries
[1]. These are likely to be underestimates as many have
mild or subclinical infection, and serological testing is
imperfect and not always performed.
The disease follows a biphasic course [3]. An initial
‘infective’ or ‘septicemic’ phase lasts for 4 to 7 days dur-
ing which leptospires can be found in the blood and the
cerebrospinal fluid. Symptoms at this stage are non-
specific and include fever, headache, myalgia, abdominal
pain and uveitis. This is followed by a period of 1 to 3
days during which the fever resolves. An ‘immune’ phase
follows, during which leptospires are excreted in the
urine and anti-Leptospira immunoglobulin M (IgM)
antibodies develop in the blood [1]. At this stage patients* Correspondence: dominictaylor@doctors.org.uk
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sometimes aseptic meningitis. Five to 10 percent of
patients progress to the severe form of the disease
which is also known as Weil’s disease [3]. This comprises
jaundice due to hepatocellular dysfunction rather than
hepatic necrosis and multi-organ involvement including
acute kidney injury (AKI), pulmonary hemorrhage and
adult respiratory distress syndrome.
Penicillins may shorten the duration of disease if given
during the infective phase and have been shown to re-
duce urinary shedding of leptospires [4]. Treatment of
severe disease after this stage is supportive, and may re-
quire intensive care support. There is also evidence of
benefit from methylprednisolone in severe leptospirosis
if given before the onset of multi-organ failure [5]. There
is a considerable risk of death especially in cases with
pulmonary involvement, where reported survival rates
are as low as 16% [6]. However, there have been reports
of the use of plasma exchange in such patients with
positive outcomes [6-8]. We report successful treatment
with plasma exchange in severe leptospirosis and discuss
the possible mechanisms of action.Case presentation
A 67-year-old, male Caucasian livestock hauler presented
to our acute medical unit with a 5-day history of
lethargy and myalgia. He complained of dysuria with
dark, malodorous urine, vomiting and hiccoughs. He wasMed Central Ltd. This is an Open Access article distributed under the terms of
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repair only. He took no regular medications but had been
prescribed trimethoprim for presumed urinary tract infec-
tion 1 day previously.
On examination he was icteric, his temperature was
37.6°C and he was clinically dehydrated. Initial blood pres-
sure (BP) was 118/65mmHg, heart rate 100 beats per mi-
nute. He had right upper quadrant abdominal tenderness
but no evidence of peritonitis.
Initial blood tests revealed hemoglobin 78g/L (7.8g/dL),
total white cell count 20×103/μL, neutrophils, 18.3×103/μL
and platelet count 44×103/μL. Coagulation parame-
ters were in the normal range. Serum creatinine was
4.87mg/dL (431umol/L) and serum urea 63.9mg/dL
(22.8mmol/L). Bilirubin was 12.9mg/dL (221μmol/L), al-
kaline phosphatase 236IU/L, and alanine transaminase
(ALT) 152IU/L. C-reactive protein level was 280.2mg/L
(2660mmol/L). Urine dipstick was positive for blood,
protein and bilirubin and Proteus mirabilis was isolated
on urine culture. Ultrasonography revealed normal ap-
pearances of the liver and bile ducts, and normal-sized
kidneys with a non-obstructing left-sided staghorn calcu-
lus. Leptospirosis was considered as a cause of his illness.
Serological testing was requested and he was treated ini-
tially with piperacillin-tazobactam.
Within 12 hours of admission he became hypotensive
with BP 60/40mmHg, developed new onset atrial fibrilla-
tion and his temperature rose to 38.5°C. He remained
hypotensive despite receiving 4.5L of intravenous fluid,
and was transferred to the critical care unit. He required
circulatory support with metaraminol up to 70mg/hour
and later norepinephrine up to 0.3mg/hour. He devel-
oped hemoptysis and his respiratory function quickly
deteriorated necessitating non-invasive ventilation. Despite
circulatory support, he became anuric and continuous
renal replacement therapy was initiated. He was given
intravenous hydrocortisone 200mg followed by intravenous
methylprednisolone 500mg and doxycycline was added.
After 48 hours, he developed marked hyperbilirubinemia
with bilirubin 32.2mg/dL (550μmol/L) and fulminant liver
failure with grade II hepatic encephalopathy. Chest radiog-
raphy revealed diffuse alveolar edema. Blood film revealed
no evidence of micro-angiopathic hemolytic anemia and
the most probable diagnosis was thought to be leptospir-
osis, although serological evidence was not yet available.
On the 5th day after admission, plasma exchange was initi-
ated. Over the next 48 hours he underwent two 4-litre ex-
changes using a combination of fresh frozen plasma and
human albumin solution. Biochemical parameters, timing
of renal replacement therapy and plasma exchange, as well
as respiratory and circulatory support requirements are
shown in Figure 1. Renal biopsy was not performed due to
thrombocytopenia and the increased risk of bleeding
after plasma exchange.After two plasma exchange sessions, there was a dra-
matic reduction of the serum bilirubin to 10.5mg/dL
(180μmol/L) and of the ALT to 2.7mg/dL (47μmol/L).
His mental state and respiratory function also im-
proved significantly. It was possible to gradually with-
draw vasopressors and respiratory support and the patient
became oriented and alert. Further plasma exchange ses-
sions were not deemed necessary owing to this dramatic
improvement. At this point, serological testing was nega-
tive for hepatitis A, B, C and E, human immunodeficiency
virus, Epstein–Barr virus, cytomegalovirus and Borrelia
burgdorferi. Initial serology for Leptospira IgM was
also negative.
Seven days after starting plasma exchange, he was trans-
ferred to our renal unit for intermittent hemodialysis, and
after 9 days his renal function had recovered suffi-
ciently to stop renal replacement therapy. After 14
days, Leptospira IgM was tested as positive, followed
by a positive Leptospira microscopic agglutination test
(MAT) tested 30 days after presentation. The patient
remains well, with normal liver function tests and a serum
creatinine of 1.52mg/dL (135umol/L).
Discussion
This patient developed severe sepsis with AKI and
multi-organ failure 5 to 7 days after the onset of symp-
toms of Leptospira infection, coinciding with the im-
mune phase of the disease. Notably, he had pulmonary
involvement which is a predictor of poor outcome [6].
The most common mechanism of renal injury in
leptospirosis is tubulointerstitial nephritis with intersti-
tial edema and a cellular infiltrate. This typically mani-
fests as non-oliguric AKI, with hypokalemia caused by
resulting tubular dysfunction [9]. In our case, there
was oligo-anuria with no such electrolyte disturbance
suggesting an alternative mechanism of AKI. As can be
seen in Figure 1, initiation of plasma exchange led to an
immediate improvement in serum bilirubin and ALT.
Cardiovascular and respiratory function also improved
dramatically allowing vasopressors and respiratory sup-
port to be withdrawn. His urine output improved 21
days after the onset of symptoms, followed by reso-
lution of AKI.
There are other reports of severe leptospirosis treated
successfully with plasma exchange. Tse et al. [7] de-
scribed a patient with multi-organ failure including pul-
monary infiltrates who improved dramatically after one
plasma exchange only. Another patient was treated suc-
cessfully with a series of five plasma exchanges, but suf-
fered significant morbidity as a result of treatment
complications [8]. Trivedi et al. [6] report a case series of
114 patients with leptospirosis complicated by pulmon-
ary hemorrhage that were treated either with two plasma
exchange sessions and one dose of cyclophosphamide, or
Figure 1 Changes in biochemical indices and critical care requirements with plasma exchange and renal replacement therapies.
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those treated with plasma exchange was 77% compared
with 17% in those treated with supportive treatment
alone. The mechanism by which plasma exchange results
in the observed clinical and biochemical improvement of
patients with severe leptospirosis is not fully understood.
We have outlined possible mechanisms below:
1) Plasma exchange may disrupt the mechanisms
causing tissue damage in severe sepsis.
In the infective phase of leptospirosis, systemic
inflammation can cause endovascular injury similar
to that occurring in severe sepsis [9]. The outer
membrane of Leptospira shares characteristics of
both Gram-positive and Gram-negative bacteria. Its
main components are phospholipids, outer
membrane proteins (OMP) and lipopolysaccharides
(LPS) that act as endotoxins [3]. In the bloodstream,
the binding of LPS to toll-like receptors (TLR)4 on
the surface of B lymphocytes results in the
activation of B-cells and the production of IgM
against the LPS of Leptospira [10]. Leptospiral IgM
can opsonize the bacteria and promote their
phagocytosis and killing by neutrophils and
macrophages. Leptospira that survive this immune
response are able to evade complement-mediated
killing and quickly disseminate and colonize the liver
and their other main target organs which are the
lung and the kidney [3]. In the liver and kidneys,
leptospiral LPS binds to TLR2 and TLR4 causing
activation of B-cells and T-cells [10]. Activated B
and T-cells secrete interferon-γ that promote the
killing of Leptospira, but also produce pro-
inflammatory cytokines such as interleukin-6 (IL-6)
and tumor necrosis factor (TNF) leading to tissue
inflammation [10]. TNF and IL-6 are also important
mediators in the pathogenesis of meningococcal
infection, but plasma exchange had minor or no
effect in the plasma concentration of these cytokinesin patients with meningococcal infection [11].
The evidence in the literature for the use of
plasma exchange in sepsis is conflicting, because
non-randomized clinical trials and case series
report survival benefit, whereas two randomized
controlled trials found no benefit [12].
2) Plasma exchange may prevent immune complex-
mediated tissue injury.
Although vasculitis has been demonstrated in
histological specimens from cases with severe
leptospirosis, it has not been a persistent finding
neither is it thought to be the primary pathological
mechanism [13]. In the immune phase of the
disease, there is evidence for the development of
pathogenic immune complexes and the
disappearance of these complexes coincides with
improvements in liver and kidney function [14]. In
murine models, activation of TLR by viral antigens
can induce immune complex glomerulonephritis
[15], but such a response has not been observed in
leptospirosis. Instead, activation of TLR2 and TLR4
by LPS on renal epithelial cells is thought to cause
tubulointerstitial nephritis [3,8]. In addition,
leptospiral OMP has also been shown to cause
accumulation of extracellular matrix in tubular cells
contributing to the development of renal fibrosis [3].
The pathophysiology of lung injury in severe leptospir-
osis is also unclear and is thought to be induced either
by unidentified toxins or by an autoimmune mechanism.
The deposition of IgM, IgA, IgG and C3 in the alveolus
of patients with pulmonary hemorrhage secondary to
leptospirosis and in a guinea pig model of severe pul-
monary leptospirosis is similar to the pattern seen in
Goodpasture’s syndrome [3,9]. However, sera from pa-
tients with leptospirosis did not recognize the human
glomerular basement membrane (GBM) and it is there-
fore unlikely that the lung disease seen in leptospirosis is
caused by an anti-GBM antibody mechanism [3].
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lenging and in our case the diagnosis was made on the
basis of the clinical picture. The available serological tests
for Leptospira are an enzyme immunoassay (EIA), measur-
ing leptospiral IgM, and a MAT. The EIA becomes positive
from 5 days after infection, but can take longer, especially
if antibiotics have been administered. Confirmation by
MAT is recommended, which may be positive from the
10th day after the onset of symptoms [1].
Conclusion
In summary, our patient had features of severe leptospir-
osis, with AKI and pulmonary involvement. Despite pre-
dictors for poor outcome, his clinical condition and
biochemical parameters improved dramatically after two
plasma exchanges. Although it is possible that the pa-
tient recovered spontaneously with supportive manage-
ment, his dramatic improvement leads us to believe that
plasma exchange had a vital role in his recovery. We
hypothesize that plasma exchange prevents injury medi-
ated by sepsis or by an unknown immune mechanism in
severe leptospirosis. In our experience, serological test-
ing was not helpful due to the long delay to a positive
result and we recommend treatment based on the clin-
ical picture. We advocate the use of plasma exchange in
deteriorating severe disease necessitating intensive care
support despite standard treatment with antibiotics.
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